Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - DS HEALTHCARE GROUP, INC. | dskx_ex99z1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
______________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 24, 2012
______________
DS HEALTHCARE GROUP, INC.
(Exact name of registrant as specified in its charter)
______________
Florida |
| 000-53680 |
| 20-8380461 |
(State or other jurisdiction |
| (Commission |
| (I.R.S. Employer |
1601 Green Road, Pompano Beach, Florida 33064
(Address of principal executive offices) (Zip Code)
(888) 404-7770
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02.
Results of Operations and Financial Condition.
On April 24, 2013, DS Healthcare Group, Inc. (the "Company") issued a press release to announce its financial results for the fiscal year ended December 31 2012. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On April 18, 2013, the Company received notice from NASDAQ Stock Market LLC indicating that it did not comply with certain of NASDAQ’s continued listing standards due to its delinquent filing of its annual report on Form 10-K for the year ended December 31, 2012 as set forth in NASDAQ Listing Rule 5250(c)(i). Upon filing of the annual report on April 24, 2013, the Company regained compliance with NASDAQ continued listing standards.
Item 7.01
Regulation FD Disclosure.
On April 24, 2013, the Company issued a press release announcing the receipt of the notice from NASDAQ described in Item 3.01 of this report and its financial results for the fiscal year ended December 31, 2012. A copy of this press release is furnished as Exhibit 99.1 to this report.
The information furnished with this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01
Financial Statements and Exhibits.
(d)
Exhibits.
Exhibit No. |
| Description |
|
|
|
99.1 |
| Press release dated April 24, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| DS HEALTHCARE GROUP, INC. |
| |
|
|
|
|
Date: April 24, 2013 | By: | /s/ Daniel Khesin |
|
| Name: | Daniel Khesin |
|
| Title: | Chief Executive Officer |
|